Simplex Trading, LLC Tempest Therapeutics, Inc. Transaction History
Simplex Trading, LLC
- $3.28 Billion
- Q4 2024
A detailed history of Simplex Trading, LLC transactions in Tempest Therapeutics, Inc. stock. As of the latest transaction made, Simplex Trading, LLC holds 18,913 shares of TPST stock, worth $15,508. This represents 0.0% of its overall portfolio holdings.
Number of Shares
18,913
Previous 13,077
44.63%
Holding current value
$15,508
Previous $18,000
16.67%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding TPST
# of Institutions
39Shares Held
6.35MCall Options Held
34.9KPut Options Held
148K-
Versant Venture Management, LLC San Francisco, CA3.51MShares$2.88 Million4.35% of portfolio
-
Black Rock Inc. New York, NY550KShares$451,1970.0% of portfolio
-
Jane Street Group, LLC New York, NY493KShares$404,3370.0% of portfolio
-
Geode Capital Management, LLC Boston, MA354KShares$290,5060.0% of portfolio
-
Ubs Group Ag196KShares$160,4540.0% of portfolio
About Tempest Therapeutics, Inc.
- Ticker TPST
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 10,418,900
- Market Cap $8.54M
- Description
- Tempest Therapeutics Inc., a clinical-stage oncology company, engages in developing small molecule therapeutics to treat cancer. The company's two clinical programs are TPST-1495, a dual antagonist of EP2 and EP4, receptors of prostaglandin E2, and is currently in a Phase 1 trial in solid tumors; and TPST-1120, a selective antagonist of peroxiso...